Maternal-Fetal Antimicrobials
Penicillin G / Clindamycin + Gentamicin / Ceftriaxone / Metronidazole
Indicators and dose
Mechanism of Action and Specific Obstetric Indications
Penicillin G Sodium (Wall Bactericide)
Betal-lactam inhibitor of bacterial peptidoglycan cross-linking:
- Intrapartum prophylaxis of Group B Streptococcus (GBS / S. agalactiae): A mandatory choice to prevent early neonatal sepsis, meningitis and pneumonia in the newborn.
- Treatment of gestational syphilis (Penicillin G benzathine).
- Treatment of gestational listeriosis (associated with ampicillin).
Clindamycin + Gentamicin (Combined Scheme)
Synergistic ribosomal blockade (50S anaerobic / 30S Gram-negative):
- Empirical treatment of active chorioamnionitis (intra-amniotic infection) after prolonged rupture of membranes.
- Treatment of acute postpartum endometritis.
- Intrapartum prophylactic alternative scheme for GBS in patients with confirmed severe allergy (anaphylaxis) to penicillin.
Dosage and Protocols
- Intrapartum GBS prophylaxis (Penicillin G): Initial bolus of 5 million IU IV slowly, followed by doses of 2.5 to 3 million IU IV every 4 hours until delivery is complete. A minimum of 4 hours of infusion should be guaranteed prior to birth to achieve optimal cord-fetal bactericidal levels.
- Chorioamnionitis / Endometritis (Clindamycin + Gentamicin): Clindamycin 900 mg IV every 8 hours + Gentamicin 1.5 mg/kg IV every 8 hours (or single daily dose of 5 mg/kg), maintaining the combination until the patient is afebrile for more than 24-48 hours.
Pregnancy and Breastfeeding
FDA risk categories should always be considered when selecting the antimicrobial therapy of choice. Generally compatible with breastfeeding, with care to monitor alterations in the infant's intestinal flora (such as transient diarrhea or oral candidiasis).
Security
Gestational Safety and Teratogenicity Profiles
| Active Substance | FDA Category | Transplacental Passage | Known Fetal/Neonatal Toxicity |
|---|---|---|---|
| Penicillin G / Ampicillin | B | Excellent passage into fetal circulation and amniotic fluid | Safe in all phases of gestation. It is not associated with structural abnormalities or cellular toxicity. |
| Gentamicin (Aminoglycoside) | D | Moderate to rapid rate | Risk of bilateral fetal ototoxicity and nephrotoxicity due to accumulation in the inner ear and developing fetal kidneys (use only with monitoring of serum levels). |
| Ceftriaxone (Cephalosporin 3rd gen) | B | Excellent diffusion to fetal tissues | Safe during pregnancy. Neonatal caution: it can displace bilirubin from albumin, increasing the risk of jaundice and kernicterus in preterm birth. |
| Metronidazole (Antiprotozoal / Anaerobic) | B | Crosses the placental barrier freely | Demonstrated safety in the second and third trimester for the treatment of vaginosis and trichomoniasis; avoid high doses in the first trimester due to theoretical mutagenic risk (without clinical confirmation). |
Epistemis is educational review material. It is not a medical device, does not diagnose or prescribe treatment, and does not replace formal medical training, current clinical guidelines, or professional clinical judgment.
- System
- Gynecology and Obstetrics
- Cluster
- Anti-infectives in Obstetrics